| Name | long intergenic non-protein coding RNA 152 |
| Description | This gene produces a long non-coding RNA that is overexpressed in cancer cells and promotes cell proliferation and epithelial-mesenchymal transition. This RNA may bind enhancer of zeste homolog 2 and participate in the transcriptional silencing of tumor suppressor genes. It may act as a sponge for microRNAs. Alternatively spliced variants have been observed. [provided by RefSeq, Dec 2017] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n LINC00152, also known as CYTOR, is frequently overexpressed in diverse cancers—including gastric, colon, hepatocellular, non‐small cell lung, and triple‐negative breast cancers—and its elevated expression correlates with aggressive clinicopathological features such as larger tumor size, deeper invasion, enhanced metastasis, and poorer overall survival."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Mechanistically, LINC00152 appears to promote oncogenesis through multiple pathways. In gastric and lung cancers, it interacts with epigenetic regulators such as EZH2 to repress tumor suppressor genes—including p15, p21, and IL24—thereby stimulating cell cycle progression and proliferation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}, {"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In colon cancer and triple‐negative breast cancer, LINC00152 functions as a competing endogenous RNA to sponge microRNAs (for example, miR‑193a‑3p), which results in the de‐repression of targets such as ERBB4 and ETS1; these events lead to activation of downstream signaling cascades including the PI3K/AKT and mTOR pathways and confer chemoresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "10"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition, direct binding of LINC00152 to proteins such as EGFR has been shown to further activate the PI3K/AKT signaling cascade in gastric and lung cancers"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}, {"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ", while its critical role in cell cycle regulation is underscored by findings that depletion of LINC00152 leads to arrest during mitosis, particularly in prometaphase."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, in hepatocellular carcinoma LINC00152 has been implicated in the activation of the mTOR pathway and the promotion of cell cycle progression via upregulation of CCND1"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": ", while its involvement as a serum biomarker in gastric cancer further supports its potential clinical utility."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings demonstrate that LINC00152 acts as a multifaceted oncogene by modulating key signaling and epigenetic mechanisms that drive tumor proliferation, invasion, metastasis, and chemoresistance. The diverse functional roles of LINC00152 underscore its value as a promising diagnostic biomarker and therapeutic target across multiple cancer types.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Qianqian Pang, Jiaxin Ge, Yongfu Shao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-1709-3"}], "href": "https://doi.org/10.1007/s13277-014-1709-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24523021"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24523021"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Tian Yang, Hongmei Zeng, Wanqing Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Helicobacter pylori infection, H19 and LINC00152 expression in serum and risk of gastric cancer in a Chinese population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canep.2016.08.015"}], "href": "https://doi.org/10.1016/j.canep.2016.08.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27592063"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27592063"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Qin-Nan Chen, Xin Chen, Zhen-Yao Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-017-0581-3"}], "href": "https://doi.org/10.1186/s12943-017-0581-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28109288"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28109288"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jiali Wu, Zeyu Shuang, Jianfu Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2017.11.055"}], "href": "https://doi.org/10.1016/j.biopha.2017.11.055"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29156515"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29156515"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Xin Deng, Xiao Fang Zhao, Xing Qiu Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2017.03.031"}], "href": "https://doi.org/10.1016/j.biopha.2017.03.031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28343069"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28343069"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yan Zhang, Cheng Xiang, Yuling Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR/PI3K/AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2017.07.120"}], "href": "https://doi.org/10.1016/j.biopha.2017.07.120"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28787699"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28787699"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Wen-ming Chen, Ming-de Huang, Dao-ping Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6949"}], "href": "https://doi.org/10.18632/oncotarget.6949"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26799422"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26799422"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ben Yue, Donglan Cai, Chenchen Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Ther (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mt.2016.180"}], "href": "https://doi.org/10.1038/mt.2016.180"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27633443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27633443"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Xue Wang, Hongfei Yu, Wenjie Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-018-0860-7"}], "href": "https://doi.org/10.1186/s12943-018-0860-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30064438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30064438"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Haifang Wang, Wenxiang Chen, Peng Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384047.2018.1529124"}], "href": "https://doi.org/10.1080/15384047.2018.1529124"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30404587"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30404587"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Jianping Zhou, Xiaofei Zhi, Linjun Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-015-0250-6"}], "href": "https://doi.org/10.1186/s13046-015-0250-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26538117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26538117"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Linda Nötzold, Lukas Frank, Minakshi Gandhi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The long non-coding RNA LINC00152 is essential for cell cycle progression through mitosis in HeLa cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-02357-0"}], "href": "https://doi.org/10.1038/s41598-017-02357-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28536419"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28536419"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Jie Ji, Junwei Tang, Lei Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.5970"}], "href": "https://doi.org/10.18632/oncotarget.5970"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26540343"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26540343"}]}]}]}
|
| Synonyms | C2ORF59, NCRNA00152, CYTOR |
| NCBI Gene ID | 112597 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LINC00152 has 1,837 functional associations with biological entities spanning 6 categories (molecular profile, organism, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 27 datasets.
Click the + buttons to view associations for LINC00152 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of LINC00152 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of LINC00152 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of LINC00152 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of LINC00152 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00152 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of LINC00152 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of LINC00152 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00152 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at LINC00152 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of LINC00152 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of LINC00152 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with LINC00152 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing LINC00152 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of LINC00152 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of LINC00152 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of LINC00152 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of LINC00152 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of LINC00152 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of LINC00152 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of LINC00152 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00152 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of LINC00152 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain LINC00152 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of LINC00152 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of LINC00152 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at LINC00152 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of LINC00152 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |